Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq ultrasound platform, Epiq CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. According to Philips, 95 percent of a group of clinicians who were shown the new system believed it offered improved image quality: sharper and clearer images [1]. Philips is also introducing the Epiq CVxi, specifically tailored for use in the interventional lab. Both systems are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS) 5 featuring a new, automated Cancer Screening Module. The module is designed for tracking, communicating and reporting on patients who may be at a higher risk for developing cancer.